$INO 3 NEW DEVELOPMENTS.            INO 4800 to be studied in S Korea as both a vaccine &amp; treatment. 160 patients to enroll in phase 2. Applying for approval after phase 2  $MRNA $JNJ $VIR $BNTX $GILD $SPY $XBI https://t.co/NRYEPqu2v8